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Previews
HIV-1 Transcription: Activation
Mediated by Acetylation of Tat
Acetylation of HIV-1 Tat stimulates transcriptional
elongation by dissociating Tat from TAR, a transacti-
vation response RNA element in nascent HIV-1 tran-
scripts. In the March issue of Molecular Cell, Mujtaba
et al. show that the bromodomain of PCAF acetylase
specifically binds to acetylated Tat and leads to disso-
ciation of Tat from TAR.
Transcription elongation is a critical rate-limiting step
for transcription of proviral DNA of human HIV-1. In the
HIV-1 promoter, RNA polymerase II (RNAPII) activity is
stalled shortly after initiation of transcription (see Figure,
panel A). Previous work showed that two cellular com-
plexes, DSIF (DRB sensitivity-inducing factor) and NELF
(negative elongation factor), function together to block
elongation [1, 2]. DSIF is composed of hSPT4 and hSPT5
(human homologs of yeast factors which affect tran-
scriptional elongation), while NELF is composed of at
least five subunits, including WHSC2 (a factor which
appears to be targeted by the viral elongation-stimulat-
ing factor, hepatitis delta antigen) and RD (a putative
RNA binding protein).
Although binding of DSIF and NELF to RNAPII shortly
after initiating RNA synthesis leads to inhibition of elon-
gation, this step is regulated by the phosphorylation of
CTD (carboxy-terminal domain) of the largest subunit of
RNAPII (see Figure, panel B). Importantly, in a nuclear
extract, DSIF and NELF tightly bind to hypophosphory-
lated RNAPII, but not to the hyperphosphorylated form,
suggesting that phosphorylation of CTD causes dissoci-
ation of these negative factors from RNAPII.
How is repression by DSIF and NELF counteracted in Stimulation of Transcriptional Elongation by HIV-1 Tat
HIV-1 transcription? HIV-1 Tat plays a key role in such (A and B) Shortly after initiation of transcription, DSIF and NELF
derepression. First, Tat forms a complex with the posi- bind to hypophosphorylated RNAPII to block elongation. In addition,
tive elongation factor P-TEFb, which is composed of nascent transcripts, DNA elements, and/or chromatin structure
might be involved in stalling RNAPII. At this stage, CTD might becyclin T1 and CDK9 (see Figure, panel C). Then, the
partially phosphorylated by the general transcription factor TFIIH.Tat/P-TEFb complex is tethered to the RNA element
(B) Tat, by forming a complex with the positive elongation factorin nascent HIV-1 transcripts, called TAR. Accordingly,
P-TEFb, is recruited on the RNA element in HIV-1 nascent transcripts
P-TEFb phosphorylates CTD. Thus, recruitment of the called TAR.
CTD kinase P-TEFb on TAR RNA via Tat could be a key (C) P-TEFb phosphorylates CTD, leading to dissociation of DSIF
and NELF from RNAPII. This step is stimulated by the acetylationstep to form a full-length transcript [3].
of Lys28 of Tat with PCAF.As is well known, histone acetylases, by acetylating
(D) Acetylation of Lys50 by p300/CBP leads to dissociation of Tathistone tails, contribute to transcriptional activation in
from TAR. This step involves binding of Lys50-acetylated Tat with
chromatin contexts [4, 5]. Similarly, the p300/CBP and the PCAF bromodomain. Note that PCAF may exist in the elongation
PCAF histone acetylases help transactivation of HIV-1. complex.
These acetylases form a substoichiometric complex and
act together in many promoters, such as p53-responsive
promoters. p300/CBP and PCAF have distinct substrate “flags” that are recognized by other factors responsible
for transactivation.specificities in nucleosomes: while p300/CBP acetylates
mostly lysine residues which are acetylated in vivo, The bromodomain is a potential target for acetylated
histones. The double bromodomain module of TAFII250PCAF acetylates only Lys14 on histone H3. Although
exactly how histone acetylation contributes to transacti- has been shown to interact with the histone H4 tail in
an acetylation-dependent manner [6], although it is stillvation is still unclear, acetylated histones likely serve as
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unclear how this interaction contributes to activation. near future. Jones and colleagues demonstrated that
While p300/CBP and PCAF could activate HIV-1 tran- binding of cyclin T1 (a subunit of P-TAFb) to Tat signifi-
scription by acetylating nucleosomal histones, they also cantly increases the affinity and specificity of the inter-
acetylate Tat [7, 8]. Interestingly, p300/CBP and PCAF action between Tat and TAR RNA: the Tat/cyclin T1
appear to contribute to HIV-1 activation via alternative complex recognizes sequences in the loop of TAR RNA,
mechanisms by acetylating distinct residues of Tat. while Tat alone does not [10]. Therefore, it is important
Acetylation of Lys28 by PCAF has been shown to stimu- to demonstrate whether the PCAF bromodomain disso-
late interaction of Tat with P-TEFb, whereas acetylation ciates Tat from the Tat-P/TAFb complex bound to TAR
of Lys50 by p300/CBP leads to dissociation of Tat from RNA.
TAR.
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A Glimpse of the Catalytic Core
of a Group II Intron comparison [1–4].
Group II introns are found in eubacteria and in the
organellar genomes of fungi and plants. The best char-
acterized of these, ai5, excises itself from pre-mRNAA paper in a recent issue of Science describes the first
by several related RNA-catalyzed pathways: two cishigh-resolution structure of part of the catalytic core
pathways, branching or hydrolysis, and a newly recog-of a group II intron that will allow more detailed com-
nized trans pathway. The branching pathway is chemi-parisons between the excision of introns by self-splic-
cally identical to the excision of nuclear pre-mRNA in-ing group II introns and by nuclear pre-mRNA introns.
trons by the U2- and U12-dependent spliceosomes,
involving two sequential transesterification reactions
The processes by which self-splicing group II introns (Figure 1A, pathway 1): (i) nucleophilic attack by an ade-
and nuclear pre-mRNA introns are excised have long nosine 2OH within the intron (the branch site) at the 5
been compared and contrasted. The former occurs by splice site phosphate, forming a free exon 1 intermediate
an RNA-only mechanism, and the latter within a large and a lariat intron, followed by (ii) attack of the free
RNP assemblage, the spliceosome. Yet both systems exon 1 3OH at the 3 splice site, resulting in exon-
share strikingly similar structural features within their exon ligation and release of the intron. The hydrolysis
cores. So far, however, no high-resolution structural in- pathway uses water or hydroxide as the first step nu-
cleophile, followed by a second step chemically identi-formation has existed. Now, a new structure of core
